Skip to main content
    • Aa
    • Aa
  • Access
  • Cited by 25
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Glanville, Julie M. Brown, Sam Shamir, Raanan Szajewska, Hania and Eales, Jacqualyn F. 2015. The scale of the evidence base on the health effects of conventional yogurt consumption: findings of a scoping review. Frontiers in Pharmacology, Vol. 6,

    Okuma, Chihiro Ohta, Takeshi Tadaki, Hironobu Hamada, Hiromi Oda, Tomohiro Taniuchi, Hideyuki Yamanaka, Kenji Ishii, Yukihito Ohe, Yasuhiro Yata, Shinji Nishiu, Jun Aratsu, Yusuke Oshida, Shinichi Kume, Shinichi and Kakutani, Makoto 2015. JTP-103237, a novel monoacylglycerol acyltransferase inhibitor, modulates fat absorption and prevents diet-induced obesity. European Journal of Pharmacology, Vol. 758, p. 72.

    Rosenbaum, Michael Knight, Rob and Leibel, Rudolph L. 2015. The gut microbiota in human energy homeostasis and obesity. Trends in Endocrinology & Metabolism, Vol. 26, Issue. 9, p. 493.

    Tomimoto, Daisuke Okuma, Chihiro Ishii, Yukihito Akiyama, Yoshiyuki Ohta, Takeshi Kakutani, Makoto Ohkuma, Yoshiaki and Ogawa, Nobuya 2015. Pharmacological Characterization of [<i>trans</i>-5′-(4-Amino-7,7-dimethyl-2-trifluoromethyl-7<i>H</i>-pyrimido[4,5-<i>b</i>][1,4]oxazin-6-yl)-2′,3′-dihydrospiro(cyclohexane-1,1′-inden)-4-yl]acetic Acid Monobenzenesulfonate (JTT-553), a Novel Acyl CoA:Diacylglycerol Transferase (DGAT) 1 Inhibitor. Biological & Pharmaceutical Bulletin, Vol. 38, Issue. 2, p. 263.

    Feltrin, Kate L. Brennan, Ixchel M. Rades, Thomas Horowitz, Michael and Feinle-Bisset, Christine 2014. Acute oral administration of lauric acid reduces energy intake in healthy males. e-SPEN Journal, Vol. 9, Issue. 2, p. e69.

    Mera, Yasuko Hata, Takahiro Ishii, Yukihito Tomimoto, Daisuke Kawai, Takashi Ohta, Takeshi and Kakutani, Makoto 2014. JTT-130, a Novel Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein, Reduces Food Preference for Fat. Journal of Diabetes Research, Vol. 2014, p. 1.

    Sumithran, Priya and Proietto, Joseph 2014. Benefit-Risk Assessment of Orlistat in the Treatment of Obesity. Drug Safety, Vol. 37, Issue. 8, p. 597.

    Feinle-Bisset, Christine and Azpiroz, Fernando 2013. Dietary Lipids and Functional Gastrointestinal Disorders. The American Journal of Gastroenterology, Vol. 108, Issue. 5, p. 737.

    Liu, Jinqi Gorski, Judith N. Gold, Stephen J. Chen, Dunlu Chen, Shirley Forrest, Gail Itoh, Yoshiki Marsh, Donald J. McLaren, David G. Shen, Zhu Sonatore, Lisa Carballo-Jane, Ester Craw, Stephanie Guan, Xiaoming Karanam, Bindhu Sakaki, Junichi Szeto, Daphne Tong, Xinchun Xiao, Jianying Yoshimoto, Ryo Yu, Hong Roddy, Thomas P. Balkovec, James and Pinto, Shirly 2013. Pharmacological inhibition of diacylglycerol acyltransferase 1 reduces body weight and modulates gut peptide release-Potential insight into mechanism of action. Obesity, Vol. 21, Issue. 7, p. 1406.

    Aloulou, Ahmed Hamden, Khaled Elloumi, Dhouha Ali, Madiha Bou Hargafi, Khaoula Jaouadi, Bassem Ayadi, Fatma Elfeki, Abdelfattah and Ammar, Emna 2012. Hypoglycemic and antilipidemic properties of kombucha tea in alloxan-induced diabetic rats. BMC Complementary and Alternative Medicine, Vol. 12, Issue. 1,

    Hamden, Khaled Jaouadi, Bassem Zaraî, Nedia Rebai, Tarek Carreau, Serge and Elfeki, Abdelfattah 2011. Inhibitory effects of estrogens on digestive enzymes, insulin deficiency, and pancreas toxicity in diabetic rats. Journal of Physiology and Biochemistry, Vol. 67, Issue. 1, p. 121.

    Hata, T. Mera, Y. Tadaki, H. Kuroki, Y. Kawai, T. Ohta, T. and Kakutani, M. 2011. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses high fat diet-induced obesity and glucose intolerance in Sprague-Dawley rats. Diabetes, Obesity and Metabolism, Vol. 13, Issue. 5, p. 446.

    Little, Tanya J. and Feinle-Bisset, Christine 2011. Effects of dietary fat on appetite and energy intake in health and obesity — Oral and gastrointestinal sensory contributions. Physiology & Behavior, Vol. 104, Issue. 4, p. 613.

    Wang, Minghan 2011. Metabolic Syndrome.

    Halford, Jason C. G. Boyland, Emma J. Blundell, John E. Kirkham, Tim C. and Harrold, Joanne A. 2010. Pharmacological management of appetite expression in obesity. Nature Reviews Endocrinology, Vol. 6, Issue. 5, p. 255.

    Nair, Nivasinee S. Brennan, Ixchel M. Little, Tanya J. Gentilcore, Diana Hausken, Trygve Jones, Karen L. Wishart, Judith M. Horowitz, Michael and Feinle-Bisset, Christine 2009. Reproducibility of energy intake, gastric emptying, blood glucose, plasma insulin and cholecystokinin responses in healthy young males. British Journal of Nutrition, Vol. 101, Issue. 07, p. 1094.

    Atkinson, T. J. 2008. Central and peripheral neuroendocrine peptides and signalling in appetite regulation: considerations for obesity pharmacotherapy. Obesity Reviews, Vol. 9, Issue. 2, p. 108.

    Sarica, Kemal Akarsu, Ersin Erturhan, Sakip Yagci, Faruk Aktaran, Sebnem and Altay, Bulent 2008. Evaluation of Urinary Oxalate Levels in Patients Receiving Gastrointestinal Lipase Inhibitor. Obesity, Vol. 16, Issue. 7, p. 1579.

    Sahin, Mustafa Tanaci, Nedret Yucel, Muammer Tutuncu, Neslihan Bascil and Guvener, Nilgun 2007. The effect of single-dose orlistat on postprandial serum glucose, insulin and glucagon-like peptide-1 levels in nondiabetic obese patients. Clinical Endocrinology, Vol. 67, Issue. 3, p. 346.

    Halford, Jason C.G. 2006. Pharmacotherapy for obesity. Appetite, Vol. 46, Issue. 1, p. 6.


Lipase inhibition attenuates the acute inhibitory effects of oral fat on food intake in healthy subjects

  • Deirdre O'Donovan (a1), Christine Feinle-Bisset (a1), Judith Wishart (a1) and Michael Horowitz (a1)
  • DOI:
  • Published online: 01 March 2007

The lipase inhibitor, orlistat, is used in the treatment of obesity and reduces fat absorption by about 30%. However, the mean weight loss induced by orlistat is less than expected for the degree of fat malabsorption. It was hypothesised that lipase inhibition with orlistat attenuates the suppressive effects of oral fat on subsequent energy intake in normal-weight subjects. Fourteen healthy, lean subjects (nine males, five females; aged 25±1·3 years) were studied twice, in a double-blind fashion. The subjects received a high-fat yoghurt ‘preload’ (males 400g (2562kJ); females 300g (1923kJ)), containing orlistat (120mg) on one study day (and no orlistat on the other ‘control’ day), 30min before ad libitum access to food and drinks; energy intake was assessed during the following 8h. Blood samples were taken at regular intervals for the measurement of plasma cholecystokinin (CCK). Each subject performed a 3d faecal fat collection following each study. Energy intake during the day was greater following orlistat (10220 (sem 928) kJ) v. control (9405 (sem 824) kJ) (P=0·02). On both days plasma CCK increased (P<0·05) after the preload. Plasma CCK 20min following ingestion of the preload was less after orlistat (4·1 (sem 0·9) pmol/l) v. control (5·3) (sem 0·9) pmol/l (P=0·028); however there was no difference in the area under the curve 0–510min between the two study days. Fat excretion was greater following orlistat (1017 (sem 168) kJ) v. control (484 (sem 90) kJ) (P=0·004). In conclusion, in healthy, lean subjects the acute inhibitory effect of fat on subsequent energy intake is attenuated by orlistat and the increase in energy intake approximates the energy lost due to fat malabsorption.

    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Lipase inhibition attenuates the acute inhibitory effects of oral fat on food intake in healthy subjects
      Your Kindle email address
      Available formats
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Lipase inhibition attenuates the acute inhibitory effects of oral fat on food intake in healthy subjects
      Available formats
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Lipase inhibition attenuates the acute inhibitory effects of oral fat on food intake in healthy subjects
      Available formats
Corresponding author
*Corresponding author: Dr Christine Feinle-Bisset, fax +61 8 82233870, email
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

K Franson & S Rossner (2000) Fat intake and food choices during weight reduction with diet, behavioural modification and a lipase inhibitor. J Intern Med 247, 607614.

CG MacIntosh , M Horowitz & MA Verhagen (2001 a) Effect of small intestinal nutrient infusion on appetite, gastrointestinal hormone release, and gastric myoelectrical activity in young and older men. Am J Gastroenterol 96, 9971007.

CG MacIntosh , JE Morley & J Wishart (2001 b) Effect of exogenous cholecystokinin (CCK)-8 on food intake and plasma CCK, leptin, and insulin concentrations in older and young adults: Evidence for increased CCK activity as a cause of the anorexia of aging. J Clin Endocrinol Metab 86, 58305837.

D Matzinger , L Degen & J Drewe (2000) The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans. Gut 46, 688693.

N Read , S French & K Cunningham (1994) The role of the gut in regulating food intake in man. Nutr Rev 52, 110.

AJ Stunkard & S Messick (1985) The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 29, 7183.

J Zhi , JW Massarella & AT Melia (1994) The pharmacokinetic-pharmacodynamic (Digit Symbol Substitution Test) relationship of flumazenil in a midazolam steady-state model in healthy volunteers. Clin Pharmacol Ther 56, 530536.

WW Zung , CB Richards & MJ Short (1965) Self-rating depression scale in an outpatient clinic. Further validation of the SDS. Arch Gen Psychiatry 13, 508515.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *